SciRhom

📍 Martinsried, Germany🗓 Founded 2016👥 17 employees💰 Last funded Jun 2024
Biotechnology Research🌐 scirhom.com
Website LinkedIn
SciRhom GmbH, based in IZB Martinsried, Germany, is a biotech start-up company that translates science into the preclinical and early clinical development of novel biopharmaceuticals for the treatment of life-threatening diseases. Founded in late 2016, we develop first-in-class antibodies against iRhom2, a key modulator of several crucial pro-inflammatory signalling pathways, including TNF-alpha signalling. Following the preclinical and early clinical development of these monoclonal antibodies, we are aiming to provide superior treatment options to currently existing inhibitors of TNF-alpha signaling. SciRhom is poised to transform the lives of patients with autoimmune diseases.
2
Total investors
1
Early stage
0
Mid stage
1
Late stage
2016
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
Germany
1
France
1
Frequently asked questions
Who invested in SciRhom?
SciRhom has 2 investors on record on gritt.io, including 1 early-stage backers and 1 late-stage investors.
When did SciRhom last raise funding?
The most recent investment in SciRhom recorded on gritt.io was in June 2024.
When was SciRhom founded?
SciRhom was founded in 2016.
What industry is SciRhom in?
SciRhom operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is SciRhom based?
SciRhom is headquartered in Martinsried, Germany.